Holen Sie sich die Stockscreener-App
25.20
3.66%
0.89
Schlusskurs vom Vortag:
$24.31
Offen:
$24.61
24-Stunden-Volumen:
5.82M
Relative Volume:
1.09
Marktkapitalisierung:
$12.52B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
63.00
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+4.65%
1M Leistung:
+5.88%
6M Leistung:
+80.65%
1J Leistung:
+110.53%
1-Tages-Spanne:
$24.55
$25.63
1-Wochen-Bereich:
$23.96
$25.63
52-Wochen-Spanne:
$8.02
$25.63
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
25.20 | 12.08B | 4.45B | 205.00M | 372.00M | 0.40 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.89 | 56.23B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
127.42 | 55.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
10.98 | 48.36B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.69 | 40.01B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
485.36 | 20.62B | 3.13B | 1.27B | 1.12B | 26.39 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Hochstufung | Argus | Hold → Buy |
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Looking At The Narrative For Elanco Animal Health After New Launches And Analyst Revisions - Yahoo Finance
Guidance Update: What are Elanco Animal Health Incorporateds earnings expectationsOptions Play & Community Consensus Trade Signals - baoquankhu1.vn
S P Trends: Whats Elanco Animal Health Incorporateds historical returnWeekly Trading Summary & Fast Moving Stock Watchlists - baoquankhu1.vn
Is Elanco Animal Health Incorporated (ELAN) at an Inflection Point? - Yahoo Finance
Animal Sedative Market Outlook 2026-2033: Growth Drivers, - openPR.com
Elanco Animal Health stock hits 52-week high at 25.33 USD - Investing.com Canada
Elanco Animal Health Inc (ELAN) Stock Price Up 3.16% on Feb 5 - GuruFocus
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
Stock Report: Is Elanco Animal Health Incorporated a speculative investmentEntry Point & Fast Entry Momentum Alerts - baoquankhu1.vn
Hardman Johnston Global Equity Strategy initiated a position in Elanco Animal Health (ELAN) - MSN
Independent Advisor Alliance Purchases 76,920 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Bank of America Securities Sticks to Their Buy Rating for Elanco Animal Health (ELAN) - The Globe and Mail
Mitsubishi UFJ Trust & Banking Corp Takes $1.44 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
UBS Group Forecasts Strong Price Appreciation for Elanco Animal Health (NYSE:ELAN) Stock - MarketBeat
Great Lakes Advisors LLC Takes $9.42 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Mutual of America Capital Management LLC Takes $4.62 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Federated Hermes Inc. Grows Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Retirement Systems of Alabama Invests $12.10 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
INVESTOR ALERT AND NOTICE: Kaskela Law Firm Announces Investigation of Elanco Animal Health Inc. and Encourages Long-Term Elanco Investors with Losses to Contact the FirmELAN - ACCESS Newswire
Hardman Johnston Global Equity Strategy Initiated a Position in Elanco Animal Health (ELAN) - Insider Monkey
A Look At Elanco Animal Health (ELAN) Valuation After Recent Analyst Upgrades And Regulatory Approvals - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Has $6.10 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
How Piper Sandler’s Upgrade and New Vet-Channel Approvals Will Impact Elanco Animal Health (ELAN) Investors - Yahoo Finance
Estate Counselors LLC Makes New $4.24 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) Upgraded by Piper Sandler Amid Corporate Gains - GuruFocus
Investment Report: Is Elanco Animal Health Incorporated attractive for institutional investorsWeekly Gains Report & Daily Momentum Trading Reports - baoquankhu1.vn
Around Town: Elanco Animal Health - actionnewsjax.com
Piper Sandler Upgrades Elanco Animal Health (ELAN) to Overweight with $30 Price Target - Intellectia AI
Elanco Animal Health stock hits 52-week high at 25.0 USD - Investing.com Canada
Elanco upgraded, Zoetis downgraded at Piper Sandler (ELAN:NYSE) - Seeking Alpha
Piper Sandler upgrades Elanco as co gains traction with veterinary groups - Investing.com Canada
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement - Finviz
Breaking Down Elanco Animal Health: 5 Analysts Share Their Views - Benzinga
Feather in Her Cap Association Announces 2026 Award Winners for Outstanding Achievements in the Animal Health Industry - BlueRidgeNow.com
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Elanco (ELAN) Upgraded by Analyst with Increased Price Target - GuruFocus
Piper Sandler Upgrades Elanco Animal Health (ELAN) and Raises Pr - GuruFocus
This Elanco Animal Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Feline Vaccines Market Overview and Leading Players: Merck & Co, - openPR.com
Elanco Animal Health Incorporated $ELAN Shares Acquired by Amalgamated Bank - MarketBeat
Pet Pharmaceuticals Market Is Booming Worldwide 2026-2033 | Zoetis • Merck Animal Health • Elanco Animal Health - openPR.com
Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics - MSN
Animal Parasiticides Market with Insights from Boehringer - openPR.com
Animal Health Market Overview and Leading Players: Bayer, Ceva - openPR.com
Elanco Animal Health (NYSE:ELAN) Hits New 1-Year High on Analyst Upgrade - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Potential Amidst Market Dynamics - DirectorsTalk Interviews
Poultry Antibiotic Market Is Booming Worldwide 2026-2033 - openPR.com
The Glucosamine Supplements for Dogs Market, Global Forecast 2026-2032 | Innovation Drives Canine Glucosamine Supplement Market with New Chewable and Liquid Formats - GlobeNewswire Inc.
Veterinary Vaccines Market to Reach USD 236 Million by 2031 | CAGR - openPR.com
Anticoccidial Drugs Market to Reach USD 2.52 Billion by 2033 | - openPR.com
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):